Advertisement

Topics

Velano Vascular Company Profile

09:40 EST 15th December 2018 | BioPortfolio

Velano Vascular technologies transform patient care by enhancing the blood-draw experience during hospitalization. The company's innovative medical technologies aim to reduce the pain and discomfort associated with these procedures for patients while improving safety and efficiency for providers. Founded by a patient advocate and a physician, Velano Vascular is backed by First Round Capital, Kapor Capital, Safeguard Scientifics, White Owl Capital, Griffin Hospital, The Children’s Hospital of Philadelphia, and several health-industry veterans. Velano Vascular’s clinical collaborators include several of the leading hospital systems in the United States. More information is available at www.velanovascular.com.


News Articles [281 Associated News Articles listed on BioPortfolio]

University Hospitals Adopts Needle-Free Blood Draw Technology

University Hospitals Cleveland Medical Center adopts needle-free blood draw technology to reduce anxiety and risks for hospitalized patients. University Hospitals (UH) Cleveland Medical Center in Ohio...

Bluegrass Vascular completes enrollment of international SAVE registry with positive results

Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, has successfully complet...

Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer’s disease and vascular dementia

Increasing evidence suggests that cerebral vascular dysfunction is associated with the early stages of Alzheimer’s disease (AD). Vascular endothelial growth factor (VEGF) is one of the key players i...

LeMaitre Vascular buys BD subsidiary for about $2.3M

LeMaitre Vascular has bought Becton Dickinson's France-based subsidiary Cardial, which makes knitted and woven vascular graft -More- 

Bluegrass Vascular Announces Positive Results From Independent Study Building On Growing Body ...

SAN ANTONIO, Oct. 27, 2018 /PRNewswire/ -- Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for Read mor...

Humacyte starts US phase II vascular trauma trial of Humacyl

Humacyl is an investigational human acellular vessel (HAV), which is being evaluated for vascular replacement or reconstruction in patients with life- or limb-threatening vascular trauma. The study, w...

LeMaitre buys Applied Medical's vascular clot management biz

LeMaitre Vascular Inc. is paying $14.2mm--$11mm up front and $3.2mm in two later installments ($2mm in 12 months and $1.2m in 24 months)--to acquire Applied Medical Resources Corp.’s vascular clot m...

FDA OKs Augmented Reality GLOW800 Vascular Fluorescence

Newly approved GLOW800 provides surgeons with a 'complete view of anatomy and physiology during vascular neurosurgery, the company says. FDA Approvals

PubMed Articles [1181 Associated PubMed Articles listed on BioPortfolio]

Hypoxia Signaling in Vascular Homeostasis.

Hypoxia signaling in the vasculature controls vascular permeability, inflammation, vascular growth, and repair of vascular injury. In this review, we summarize recent insights in this burgeoning field...

Pediatric Vascular Surgical Practice Patterns.

Vascular surgeons infrequently care for pediatric patients. As such, variability in operative management and available hospital resources at free-standing children's hospitals may exist. The study aim...

Vascular Calcification Markers and Hemodialysis Vascular Access Complications.

Arteriovenous (AV) access dysfunction is a common complication in hemodialysis patients. Markers of vascular calcification are associated with cardiovascular outcomes and mortality in this population,...

Vascular Anomalies (Part I): Classification and Diagnostics of Vascular Anomalies.

 Vascular anomalies are a diagnostic and therapeutic challenge. They require dedicated interdisciplinary management. Optimal patient care relies on integral medical evaluation and a classification s...

Beyond endothelial cells: Vascular endothelial growth factors in heart, vascular anomalies and placenta.

Vascular endothelial growth factors regulate vascular and lymphatic growth. Dysregulation of VEGF signaling is connected to many pathological states, including hemangiomas, arteriovenous malformations...

Clinical Trials [1972 Associated Clinical Trials listed on BioPortfolio]

Patient Comfort With Vascular Closure

The purpose of this research study is to collect information on the amount of discomfort patients experience with one of two different vascular blood vessel closure devices, the MynxM5 Vas...

Clinical Study of POSS-PCU Vascular Grafts for Vascular Access

This study evaluates the safety and performance of a new vascular graft made of POSS-PCU as a vascular access conduit for haemodialysis. 30 patients requiring access for dialysis will be e...

Perioperative Aspirin Response in Patients Undergoing Vascular Surgery

Reduced antiplatelet activity (low response (LR)/high on-treatment platelet reactivity (HPR)) of aspirin (ALR) or clopidogrel (CLR) is associated with an increased risk of thromboembolic e...

A Feasibility Study Evaluating the Use of SafeBreak Vascular in the Geriatric Trauma Population

SafeBreak Vascular is a medical device indicated for fluid flow control during the administration of IV fluids/medication to the patient's vascular system and to aid in the prevention of u...

Study to Evaluate Safety & Effectiveness of Vascular Sealant System

To evaluate a new vascular sealant compared to control for the control of suture line bleeding after vascular reconstructive surgery.

Companies [325 Associated Companies listed on BioPortfolio]

Velano Vascular

Velano Vascular technologies transform patient care by enhancing the blood-draw experience during hospitalization. The company's innovative medical technologies aim to reduce the ...

LeMaitre Vascular

LeMaitre Vascular is a leading global provider of innovative devices for the treatment of peripheral vascular disease. We develop, manufacture, and market disposable and implantable vascular devices t...

The Foundation for Accelerated Vascular Research

The Foundation for Accelerated Vascular Research is a non-profit medical organization dedicated to accelerating research into the cause, prevention and treatment of vascular disease. Founded in 19...

Society for Vascular Surgery

The Society for Vascular Surgery (SVS) is a not-for-profit professional medical society, composed primarily of vascular surgeons, that seeks to advance excellence and innovation in vascular health thr...

Vascular Nanotransfer Technologies

Privately held VNT, based in Auburndale, Mass., is developing Drug-Coated Balloons (DCB) that are designed to be a more precise delivery vehicle and be the standard treatment of c...

More Information about "Velano Vascular" on BioPortfolio

We have published hundreds of Velano Vascular news stories on BioPortfolio along with dozens of Velano Vascular Clinical Trials and PubMed Articles about Velano Vascular for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Velano Vascular Companies in our database. You can also find out about relevant Velano Vascular Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...


Corporate Database Quicklinks



Searches Linking to this Company Record